Columbus, Ohio — According to state and local economic development sources Sarepta Therapeutics plans to invest $30,000,000.00 to build out 85,000 square feet of new space in Columbus. The company plans to occupy the new space at 435 Stelzer Road in Columbus, on or about May 1, 2021. According to the company website Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We’re ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world’s largest gene therapy manufacturing capacity. We’re collaborating with health networks and payers, rethinking pricing models for revolutionary new treatments in development. We are in a daily race to transform genetic understanding into genetic medicine. Because every day is an opportunity to save lives stolen by rare disease.

To learn more about Sarepta Therapeutics, visit http://www.sarepta.com/

Company Contact:
Doug Ingram, Chief Executive Officer
https://www.linkedin.com/in/doingram/
617-274-4000

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved